Rationale And Background

  • Surfactant therapy reduces mortality and air leaks in preterm infants with respiratory distress syndrome (RDS).
  • Standard administration traditionally required endotracheal intubation and mechanical ventilation.
  • Even brief positive pressure ventilation via an endotracheal tube can cause volutrauma, barotrauma, and biotrauma in immature saccular lungs, predisposing to bronchopulmonary dysplasia (BPD).
  • The INSURE method (Intubation, Surfactant, Extubation) was developed to minimize ventilator exposure, but positive pressure ventilation is still delivered during dosing, and premedication can cause extubation failure.
  • Less Invasive Surfactant Administration (LISA) and Minimally Invasive Surfactant Therapy (MIST) allow surfactant delivery through a thin catheter placed in the trachea while the infant remains on continuous spontaneous breathing on nasal CPAP.

Comparison Of Delivery Modalities

ParameterEndotracheal IntubationINSURELISA / MIST
Airway InterfaceEndotracheal tubeEndotracheal tubeThin vascular catheter or feeding tube (4 to 5 Fr)
Ventilation SupportMechanical ventilationHand bagging / PPV before extubationContinuous spontaneous breathing on CPAP
Positive Pressure BreathsGiven throughoutGiven during surfactant instillationZero positive pressure breaths
Risk Of BPDHighestIntermediateLowest
Premedication NeededFull sedation and muscle paralysisMild to moderate sedationMinimal sedation or non-pharmacological comfort

Techniques (Cologne vs Hobart)

Cologne Technique (LISA / Kribs Method)

  • Uses a soft, flexible 4 Fr or 5 Fr feeding tube or vascular catheter.
  • Direct laryngoscopy is performed to view the vocal cords.
  • The flexible catheter is grasped with Magill forceps and advanced 1.5 to 2.0 cm beyond the vocal cords into the subglottic space.
  • Surfactant is slowly pushed in small aliquots during spontaneous inspirations.

Hobart Technique (MIST / Dargaville Method)

  • Uses a semi-rigid 16-gauge or 18-gauge angiocatheter or vascular catheter (such as Surfcath or Lisacath).
  • The rigidity allows direct introduction through the vocal cords without using Magill forceps.
  • The catheter is advanced 1.5 cm below the cords and held steady while surfactant is instilled.

Evidence And Clinical Trials

  • NINSAPP Trial (Lancet 2015): Enrolled preterm infants 23 to 27 weeks gestation. LISA reduced the need for mechanical ventilation within 72 hours (33% vs 73%) and significantly increased survival without BPD.
  • OPTIMIST-A Trial (JAMA 2021): Evaluated MIST in preterm infants 25 to 28 weeks gestation on CPAP. MIST significantly reduced the requirement for intubation and mechanical ventilation within 72 hours (43.1% in MIST vs 58.2% in control, RR 0.76, 95% CI 0.63–0.92, $p=0.01$).
  • Cochrane Meta-Analysis: Compared to INSURE or standard intubation, LISA/MIST demonstrates:
    • Reduced risk of composite death or BPD at 36 weeks postmenstrual age (RR 0.68, 95% CI 0.57–0.81).
    • Reduced requirement for mechanical ventilation within 72 hours of life (RR 0.65, 95% CI 0.55–0.77).
    • Significant reduction in pneumothorax (RR 0.54, 95% CI 0.40–0.73).

Procedural Steps

  • Ensure the infant is stabilized on continuous nasal CPAP with a PEEP of 6 to 8 cm $H_2O$.
  • Pre-warm surfactant (Poractant alfa 200 mg/kg or Beractant 100 mg/kg) to room temperature.
  • Position the infant with neck slightly extended; keep CPAP prongs in place.
  • Perform direct laryngoscopy to expose the glottis.
  • Insert the thin catheter 1.5 to 2.0 cm through the vocal cords using Magill forceps (LISA) or directly (MIST).
  • Remove the laryngoscope blade immediately to decrease discomfort while holding the catheter firmly at the lips.
  • Slowly instill surfactant in small aliquots over 1 to 3 minutes synchronized with spontaneous inspirations.
  • Continuously monitor heart rate and oxygen saturation; if bradycardia (<100 bpm) or desaturation (<80%) occurs, pause instillation and allow recovery on CPAP.
  • Withdraw the catheter after instillation; avoid routine endotracheal suctioning for at least 4 to 6 hours.

Premedication Debate

  • Neuromuscular blockers and high-dose opioids used for conventional intubation are strictly avoided because they suppress spontaneous breathing.
  • Non-pharmacological comfort measures include swaddling, gentle containment, and oral sucrose (24%) or expressed breast milk.
  • Intravenous atropine (10 to 20 mcg/kg) can be given 5 minutes before laryngoscopy to prevent vagal bradycardia.
  • Low-dose intravenous fentanyl (0.5 to 1.0 mcg/kg) provides analgesia, but clinicians must watch for hypoventilation or chest wall rigidity and have naloxone immediately available.
  • Ketamine (0.5 to 1.0 mg/kg IV) provides analgesia and sedation while preserving spontaneous respiratory drive and pharyngeal muscle tone.

Failure Criteria And Guidelines

  • The European Consensus Guidelines on Management of RDS recommend LISA as the preferred mode of surfactant delivery in spontaneously breathing infants on CPAP.
  • Indications: Preterm infants on CPAP (PEEP $\ge 6\text{ cm }H_2O$) with an $FiO_2 \ge 0.30$ in babies $<28$ weeks gestation, or $FiO_2 \ge 0.30\text{ to }0.40$ in babies $\ge 28$ weeks gestation.
  • Criteria for rescue intubation and mechanical ventilation:
    • Persistent hypoxemia requiring $FiO_2 > 0.50$ on CPAP $\ge 7\text{ cm }H_2O$.
    • Severe respiratory acidosis with pH <7.20 and $pCO_2 > 65\text{ mmHg}$.
    • Recurrent severe apneas requiring bag-and-mask ventilation.